Project name: HLA-DQ immunogenicity – focus on 2MM1DSA
Project leaders: Anat R. Tambur & Lloyd d’Orsogna
Detailed project description:
One of the limitations of studying HLA epitopes in the context of population studies is the heterogeneity of the cohort in terms of induction therapy, maintenance immunosuppression, medication compliance, other sensitizing events during the post-transplant course (like significant infections), etc. To minimize the effects of these factors we will focus on a subpopulation of patients who receive a donor with 2 mismatches at the DQ locus, developed de-novo DSA to one of the mismatched alleles, but did not develop DSA to the other mismatched allele.
In this project we will compare qualities of the “DSA allele” as it compared with the “non-DSA allele” and compare both to the recipient alleles. Analysis will include the use of HLA-Matchmaker, EMS-2D, EMS-3D, PIRCHE-II and individual amino-acids (AA). For the qualities of the AA differences we will use PyMol simulation as guidance. Selected samples will be studied also by absorption/elution experiments.
Milestones in years:
2019: Data collection – analysis as data will be submitted
2020: Continue data collection, continue analysis, identify samples for absorption/elution studies
2021: Continue Absorption/elution studies, finalize analysis
Patient/sample description (if applicable, details, inclusion/exclusion criteria):
Subset of “Definition of Immunogenic Epitopes”. Laboratories will need to include information if serum samples are available for absorption/elution studies although absence of serum will not constitute an exclusion
Data, samples, additional assays required:
Subset of “Definition of Immunogenic Epitopes”